Coregonus clupeaformis isolate EN_2021a chromosome 39, ASM2061545v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii; Salmoniformes; Salmonidae; Coregoninae; Coregonus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036470.1.\nAssembly name: ASM2061545v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Laval University on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJAFO000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Laval University\nAssembly Date :: 14-SEP-2021\nAssembly Method :: Flye v. 2.5\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 20.0x\nSequencing Technology :: Oxford Nanopore PromethION\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Coregonus clupeaformis Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
arsenite methyltransferase, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
arsenite methyltransferase, transcript variant X2
glycogen synthase kinase-3 beta, transcript variant X4
glycogen synthase kinase-3 beta, transcript variant X2
glycogen synthase kinase-3 beta, transcript variant X3
glycogen synthase kinase-3 beta, transcript variant X1
glycogen synthase kinase-3 beta isoform X4
glycogen synthase kinase-3 beta isoform X2
glycogen synthase kinase-3 beta isoform X3
glycogen synthase kinase-3 beta isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF01290
mannose-P-dolichol utilization defect 1 protein-like
E3 ubiquitin-protein ligase TRIM7-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM7-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM7-like isoform X2
E3 ubiquitin-protein ligase TRIM7-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 6 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 6 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: IgGFc-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123482863, transcript variant X3
uncharacterized LOC123482863, transcript variant X4
uncharacterized LOC123482863, transcript variant X1
uncharacterized LOC123482863, transcript variant X2
uncharacterized protein LOC123482863 isoform X1
uncharacterized protein LOC123482863 isoform X2
metallo-beta-lactamase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
metallo-beta-lactamase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane 4 L6 family member 4, transcript variant X1
transmembrane 4 L6 family member 4, transcript variant X2
transmembrane 4 L6 family member 5 isoform X1
transmembrane 4 L6 family member 4 isoform X2
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
plasminogen activator inhibitor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
plasminogen activator inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
plasminogen activator inhibitor 1 isoform X1
plasminogen activator inhibitor 1 isoform X2
AP-1 complex subunit sigma-1A, transcript variant X2
AP-1 complex subunit sigma-1A, transcript variant X3
AP-1 complex subunit sigma-1A, transcript variant X1
AP-1 complex subunit sigma-1A isoform X1
AP-1 complex subunit sigma-1A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
histidine N-acetyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histidine N-acetyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
schwannomin-interacting protein 1, transcript variant X2
schwannomin-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chromatin complexes subunit BAP18, transcript variant X3
chromatin complexes subunit BAP18, transcript variant X4
chromatin complexes subunit BAP18, transcript variant X1
chromatin complexes subunit BAP18, transcript variant X2
chromatin complexes subunit BAP18 isoform X4
chromatin complexes subunit BAP18 isoform X3
chromatin complexes subunit BAP18 isoform X2
chromatin complexes subunit BAP18 isoform X1
polyunsaturated fatty acid 5-lipoxygenase, transcript variant X2
polyunsaturated fatty acid 5-lipoxygenase, transcript variant X1
polyunsaturated fatty acid 5-lipoxygenase
proline-, glutamic acid- and leucine-rich protein 1-like
mediator of RNA polymerase II transcription subunit 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CD99 antigen-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
CD99 antigen-like protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CD99 antigen-like protein 2, transcript variant X2
CD99 antigen-like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CD99 antigen-like protein 2, transcript variant X5
myotubularin-related protein 1-like, transcript variant X1
myotubularin-related protein 1-like, transcript variant X3
myotubularin-related protein 1-like, transcript variant X2
myotubularin-related protein 1-like, transcript variant X4
myotubularin-related protein 1-like, transcript variant X5
myotubularin-related protein 1-like, transcript variant X6
myotubularin-related protein 1-like isoform X6
myotubularin-related protein 1-like isoform X3
myotubularin-related protein 1-like isoform X5
myotubularin-related protein 1-like isoform X2
myotubularin-related protein 1-like isoform X4
myotubularin-related protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
type II inositol 3,4-bisphosphate 4-phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cerebellin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cerebellin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
receptor-interacting serine-threonine kinase 3, transcript variant X2
receptor-interacting serine-threonine kinase 3, transcript variant X1
receptor-interacting serine-threonine kinase 3, transcript variant X3
receptor-interacting serine/threonine-protein kinase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase CYLD
lysophosphatidylcholine acyltransferase 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
H/ACA ribonucleoprotein complex subunit 3-like
solute carrier family 12 member 6-like, transcript variant X2
solute carrier family 12 member 6-like, transcript variant X1
solute carrier family 12 member 6-like, transcript variant X5
solute carrier family 12 member 6-like, transcript variant X4
solute carrier family 12 member 6-like, transcript variant X3
solute carrier family 12 member 6-like isoform X1
solute carrier family 12 member 6-like isoform X4
solute carrier family 12 member 6-like isoform X3
solute carrier family 12 member 6-like isoform X2
TOX high mobility group box family member 4-A, transcript variant X3
TOX high mobility group box family member 4 isoform X3
TOX high mobility group box family member 4-A, transcript variant X1
TOX high mobility group box family member 4-A, transcript variant X2
TOX high mobility group box family member 4 isoform X1
TOX high mobility group box family member 4-A isoform X2
SPT16 homolog, facilitates chromatin remodeling subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
SPT16 homolog, facilitates chromatin remodeling subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
SPT16 homolog, facilitates chromatin remodeling subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
SPT16 homolog, facilitates chromatin remodeling subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC123482866, transcript variant X4
uncharacterized LOC123482866, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123482866, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123482866, transcript variant X1
uncharacterized LOC123482866, transcript variant X5
uncharacterized LOC123482866, transcript variant X6
uncharacterized protein LOC123482866 isoform X1
uncharacterized protein LOC123482866 isoform X4
uncharacterized protein LOC123482866 isoform X2
uncharacterized protein LOC123482866 isoform X5
uncharacterized protein LOC123482866 isoform X3
uncharacterized protein LOC123482866 isoform X6
E3 ubiquitin-protein ligase TRIM39, transcript variant X2
E3 ubiquitin-protein ligase TRIM39 isoform X2
E3 ubiquitin-protein ligase TRIM39, transcript variant X1
E3 ubiquitin-protein ligase TRIM39 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 21-like
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X2
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
NACHT, LRR and PYD domains-containing protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
butyrophilin subfamily 1 member A1, transcript variant X2
butyrophilin subfamily 1 member A1, transcript variant X1
butyrophilin subfamily 1 member A1 isoform X1
butyrophilin subfamily 1 member A1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIM39-like isoform X2
E3 ubiquitin-protein ligase TRIM39-like isoform X1
probable serine/threonine-protein kinase PknB
probable serine/threonine-protein kinase Sps1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
apolipoprotein L domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: apolipoprotein L domain-containing protein 1-like
heterogeneous nuclear ribonucleoprotein C, transcript variant X14
heterogeneous nuclear ribonucleoprotein C, transcript variant X3
heterogeneous nuclear ribonucleoprotein C, transcript variant X13
heterogeneous nuclear ribonucleoprotein C, transcript variant X2
heterogeneous nuclear ribonucleoprotein C, transcript variant X10
heterogeneous nuclear ribonucleoprotein C, transcript variant X8
heterogeneous nuclear ribonucleoprotein C, transcript variant X7
heterogeneous nuclear ribonucleoprotein C, transcript variant X9
heterogeneous nuclear ribonucleoprotein C, transcript variant X6
heterogeneous nuclear ribonucleoprotein C, transcript variant X12
heterogeneous nuclear ribonucleoprotein C, transcript variant X11
heterogeneous nuclear ribonucleoprotein C, transcript variant X5
heterogeneous nuclear ribonucleoprotein C, transcript variant X4
heterogeneous nuclear ribonucleoprotein C, transcript variant X1
heterogeneous nuclear ribonucleoprotein C isoform X2
heterogeneous nuclear ribonucleoprotein C isoform X1
heterogeneous nuclear ribonucleoprotein C isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized si:ch211-63p21.1, transcript variant X1
uncharacterized si:ch211-63p21.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized si:ch211-63p21.1, transcript variant X2
uncharacterized protein si:ch211-63p21.1 isoform X1
uncharacterized protein si:ch211-63p21.1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
coiled-coil domain-containing protein 171
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X6
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X5
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X4
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X2
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X1
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X8
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X7
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
short transient receptor potential channel 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
zinc finger BED domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
dachshund homolog 2-like, transcript variant X2
dachshund homolog 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
endonuclease domain-containing 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123482869, transcript variant X1
uncharacterized LOC123482869, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
endonuclease domain-containing 1 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
endonuclease domain-containing 1 protein-like, transcript variant X3
endonuclease domain-containing 1 protein-like, transcript variant X2
endonuclease domain-containing 1 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat and fibronectin type-III domain-containing protein 4-like
pyruvate carboxylase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC121554418, transcript variant X1
uncharacterized LOC121554418, transcript variant X2
uncharacterized LOC123482871, transcript variant X1
uncharacterized LOC123482871, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
prospero homeobox protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
prospero homeobox protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
prospero homeobox protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
prospero homeobox protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transmembrane protein 179B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transmembrane protein 179B-like isoform X1
transmembrane protein 179B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transmembrane protein 179B-like isoform X2
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
MUS81 structure-specific endonuclease subunit, transcript variant X2
MUS81 structure-specific endonuclease subunit, transcript variant X1
crossover junction endonuclease MUS81 isoform X2
crossover junction endonuclease MUS81 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative transcription factor Ovo-like 1a
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
zinc finger protein 287-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 287-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
zinc finger protein 287-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X3
zinc finger protein OZF-like, transcript variant X5
gastrula zinc finger protein XlCGF57.1-like isoform X3
gastrula zinc finger protein XlCGF57.1-like isoform X5
zinc finger protein OZF-like, transcript variant X4
gastrula zinc finger protein XlCGF57.1-like isoform X4
zinc finger protein OZF-like, transcript variant X7
zinc finger protein OZF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
gastrula zinc finger protein XlCGF57.1-like isoform X1
zinc finger protein OZF-like, transcript variant X2
zinc finger protein OZF-like, transcript variant X6
gastrula zinc finger protein XlCGF57.1-like isoform X2
gastrula zinc finger protein XlCGF57.1-like isoform X6
gastrula zinc finger protein XlCGF7.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
gastrula zinc finger protein XlCGF8.2DB-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gastrula zinc finger protein XlCGF7.1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
recombining binding protein suppressor of hairless, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
recombining binding protein suppressor of hairless isoform X1
recombining binding protein suppressor of hairless, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
suppressor of hairless protein homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
stromal interaction molecule 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stromal interaction molecule 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stromal interaction molecule 2-like isoform X1
stromal interaction molecule 2-like isoform X2
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
low affinity immunoglobulin gamma Fc region receptor II-b-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
atrial natriuretic peptide receptor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
probable ATP-dependent RNA helicase DDX58
uncharacterized LOC121554321, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC121554321, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC121554321, transcript variant X3
uncharacterized LOC121554321, transcript variant X2
aminoacyl tRNA synthase complex-interacting multifunctional protein 1
sphingomyelin synthase 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sphingomyelin synthase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phosphatidylcholine:ceramide cholinephosphotransferase 2
calcium uniporter protein, mitochondrial
complement factor I, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
complement factor I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
complement factor I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC405879 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
stress-associated endoplasmic reticulum protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
mitochondrial 2-oxoglutarate/malate carrier protein
trafficking protein particle complex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeat-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
calcium-binding protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-binding protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-binding protein 2-like isoform X1
calcium-binding protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
dynactin subunit 1, transcript variant X1
dynactin subunit 1, transcript variant X3
dynactin subunit 1, transcript variant X5
dynactin subunit 1, transcript variant X2
dynactin subunit 1, transcript variant X4
dynactin subunit 1, transcript variant X6
uncharacterized LOC121554580, transcript variant X2
uncharacterized LOC121554580, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
dedicator of cytokinesis protein 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
interleukin-5 receptor subunit alpha, transcript variant X1
interleukin-5 receptor subunit alpha, transcript variant X2
interleukin-5 receptor subunit alpha isoform X2
interleukin-5 receptor subunit alpha isoform X1
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kin of IRRE-like protein 1, transcript variant X1
kin of IRRE-like protein 1, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial-like
Fc epsilon receptor IgFc epsilon receptor Ig
high affinity immunoglobulin epsilon receptor subunit gamma
oocyte zinc finger protein XlCOF6-like, transcript variant X3
oocyte zinc finger protein XlCOF6-like, transcript variant X4
oocyte zinc finger protein XlCOF6-like, transcript variant X2
oocyte zinc finger protein XlCOF6-like, transcript variant X1
oocyte zinc finger protein XlCOF6-like isoform X2
oocyte zinc finger protein XlCOF6-like isoform X1
neuralized-like protein 4, transcript variant X1
neuralized-like protein 4, transcript variant X3
neuralized-like protein 4, transcript variant X4
neuralized-like protein 4, transcript variant X2
neuralized-like protein 4, transcript variant X5
neuralized-like protein 4, transcript variant X6
neuralized-like protein 4, transcript variant X7
rho guanine nucleotide exchange factor 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized si:dkey-19b23.8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized si:dkey-19b23.8, transcript variant X2
tumor necrosis factor ligand superfamily member 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromodomain-helicase-DNA-binding protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromodomain-helicase-DNA-binding protein 3 isoform X2
chromodomain-helicase-DNA-binding protein 3 isoform X1
cytochrome b5 domain-containing protein 1
N-alpha-acetyltransferase 38, NatC auxiliary subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane protein 272, transcript variant X2
transmembrane protein 272, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
active breakpoint cluster region-related protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ArfGAP with FG repeats 2, transcript variant X2
ArfGAP with FG repeats 2, transcript variant X3
ArfGAP with FG repeats 2, transcript variant X1
arf-GAP domain and FG repeat-containing protein 2 isoform X2
arf-GAP domain and FG repeat-containing protein 2 isoform X3
arf-GAP domain and FG repeat-containing protein 2 isoform X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1, transcript variant X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 isoform X2
solute carrier family 16 member 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BCL6B transcription repressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BCL6B transcription repressor, transcript variant X1
B-cell CLL/lymphoma 6 member B protein isoform X2
B-cell lymphoma 6 protein homolog isoform X1
thyroid hormone receptor interactor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
thyroid receptor-interacting protein 6 isoform X1
thyroid receptor-interacting protein 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
deleted in malignant brain tumors 1 protein-like
phospholipid-transporting ATPase ABCA1-like
adhesion G protein-coupled receptor L3, transcript variant X8
adhesion G protein-coupled receptor L3 isoform X8
adhesion G protein-coupled receptor L3, transcript variant X10
adhesion G protein-coupled receptor L3, transcript variant X9
adhesion G protein-coupled receptor L3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor L3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor L3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor L3 isoform X10
adhesion G protein-coupled receptor L3 isoform X9
adhesion G protein-coupled receptor L3 isoform X2
adhesion G protein-coupled receptor L3 isoform X3
adhesion G protein-coupled receptor L3 isoform X1
adhesion G protein-coupled receptor L3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G protein-coupled receptor L3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G protein-coupled receptor L3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor L3, transcript variant X4
adhesion G protein-coupled receptor L3 isoform X7
adhesion G protein-coupled receptor L3 isoform X5
adhesion G protein-coupled receptor L3 isoform X6
adhesion G protein-coupled receptor L3 isoform X4
multiple PDZ domain protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple PDZ domain protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple PDZ domain protein, transcript variant X4
multiple PDZ domain protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
5,6-dihydroxyindole-2-carboxylic acid oxidase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X1
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X15
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X4
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X17
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X8
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X18
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X3
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X16
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X5
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X19
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X10
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X12
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X25
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X26
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X28
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X29
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X30
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X7
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X31
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X6
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X42
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X9
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X43
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X11
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X13
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X14
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X22
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X40
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X20
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X21
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X23
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X24
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X27
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X41
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X35
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X32
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X33
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X36
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X37
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X34
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X38
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X39
receptor-type tyrosine-protein phosphatase delta-like, transcript variant X2
receptor-type tyrosine-protein phosphatase delta-like isoform X1
receptor-type tyrosine-protein phosphatase delta-like isoform X14
receptor-type tyrosine-protein phosphatase delta-like isoform X3
receptor-type tyrosine-protein phosphatase delta-like isoform X16
receptor-type tyrosine-protein phosphatase delta-like isoform X7
receptor-type tyrosine-protein phosphatase delta-like isoform X17
receptor-type tyrosine-protein phosphatase delta-like isoform X2
receptor-type tyrosine-protein phosphatase delta-like isoform X15
receptor-type tyrosine-protein phosphatase delta-like isoform X4
receptor-type tyrosine-protein phosphatase delta-like isoform X18
receptor-type tyrosine-protein phosphatase delta-like isoform X9
receptor-type tyrosine-protein phosphatase delta-like isoform X11
receptor-type tyrosine-protein phosphatase S-like isoform X24
receptor-type tyrosine-protein phosphatase S-like isoform X25
receptor-type tyrosine-protein phosphatase delta-like isoform X27
receptor-type tyrosine-protein phosphatase delta-like isoform X34
receptor-type tyrosine-protein phosphatase delta-like isoform X28
receptor-type tyrosine-protein phosphatase delta-like isoform X31
receptor-type tyrosine-protein phosphatase delta-like isoform X32
receptor-type tyrosine-protein phosphatase delta-like isoform X29
receptor-type tyrosine-protein phosphatase delta-like isoform X35
receptor-type tyrosine-protein phosphatase delta-like isoform X6
receptor-type tyrosine-protein phosphatase delta-like isoform X30
receptor-type tyrosine-protein phosphatase delta-like isoform X5
receptor-type tyrosine-protein phosphatase S-like isoform X41
receptor-type tyrosine-protein phosphatase delta-like isoform X36
receptor-type tyrosine-protein phosphatase delta-like isoform X33
receptor-type tyrosine-protein phosphatase delta-like isoform X8
receptor-type tyrosine-protein phosphatase S-like isoform X42
receptor-type tyrosine-protein phosphatase delta-like isoform X10
receptor-type tyrosine-protein phosphatase delta-like isoform X37
receptor-type tyrosine-protein phosphatase delta-like isoform X12
receptor-type tyrosine-protein phosphatase delta-like isoform X13
receptor-type tyrosine-protein phosphatase delta-like isoform X21
receptor-type tyrosine-protein phosphatase delta-like isoform X39
receptor-type tyrosine-protein phosphatase delta-like isoform X19
receptor-type tyrosine-protein phosphatase delta-like isoform X20
receptor-type tyrosine-protein phosphatase delta-like isoform X22
receptor-type tyrosine-protein phosphatase delta-like isoform X23
receptor-type tyrosine-protein phosphatase S-like isoform X26
receptor-type tyrosine-protein phosphatase S-like isoform X40
receptor-type tyrosine-protein phosphatase delta-like isoform X38
inactive ubiquitin carboxyl-terminal hydrolase 53
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Kv channel-interacting protein 4, transcript variant X3
Kv channel-interacting protein 4, transcript variant X2
Kv channel-interacting protein 4, transcript variant X4
Kv channel-interacting protein 4, transcript variant X1
Kv channel-interacting protein 4 isoform X3
Kv channel-interacting protein 4 isoform X2
Kv channel-interacting protein 4 isoform X4
Kv channel-interacting protein 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X1
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X7
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X5
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X8
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X6
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcript variant X4
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X8
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X7
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X6
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X5
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X4
uncharacterized LOC121554468, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC121554468, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 isoform X2
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 isoform X1
coiled-coil domain-containing protein 149, transcript variant X3
coiled-coil domain-containing protein 149, transcript variant X2
coiled-coil domain-containing protein 149, transcript variant X1
coiled-coil domain-containing protein 149 isoform X3
coiled-coil domain-containing protein 149 isoform X2
coiled-coil domain-containing protein 149 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 239, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
zinc finger protein 239, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
U2 small nuclear ribonucleoprotein A'-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Fras1 related extracellular matrix 1a, transcript variant X1
FRAS1-related extracellular matrix protein 1a isoform X1
Fras1 related extracellular matrix 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FRAS1-related extracellular matrix protein 1a isoform X2
Fras1 related extracellular matrix 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
rap1 GTPase-GDP dissociation stimulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rap1 GTPase-GDP dissociation stimulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
rap1 GTPase-GDP dissociation stimulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
rap1 GTPase-GDP dissociation stimulator 1, transcript variant X4
rap1 GTPase-GDP dissociation stimulator 1 isoform X2
rap1 GTPase-GDP dissociation stimulator 1 isoform X3
rap1 GTPase-GDP dissociation stimulator 1 isoform X1
rap1 GTPase-GDP dissociation stimulator 1 isoform X4
uncharacterized LOC121554589, transcript variant X2
uncharacterized LOC121554589, transcript variant X1
RNA (guanine-9-)-methyltransferase domain-containing protein 2
chromosome 39 C4orf54 homolog, transcript variant X3
chromosome 39 C4orf54 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized protein C4orf54 homolog isoform X1
uncharacterized protein C4orf54 homolog isoform X3
chromosome 39 C4orf54 homolog, transcript variant X2
uncharacterized protein C4orf54 homolog isoform X2
3-hydroxyacyl-CoA dehydratase 4, transcript variant X1
3-hydroxyacyl-CoA dehydratase 4, transcript variant X3
3-hydroxyacyl-CoA dehydratase 4, transcript variant X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 isoform X1
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 isoform X2
MLLT3 super elongation complex subunit, transcript variant X4
MLLT3 super elongation complex subunit, transcript variant X1
MLLT3 super elongation complex subunit, transcript variant X3
MLLT3 super elongation complex subunit, transcript variant X2
DNA damage-inducible transcript 4-like protein
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X6
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
B-cell scaffold protein with ankyrin repeats-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor 1 B-type, transcript variant X3
nuclear factor 1 B-type, transcript variant X5
nuclear factor 1 B-type, transcript variant X7
nuclear factor 1 B-type, transcript variant X1
nuclear factor 1 B-type, transcript variant X2
nuclear factor 1 B-type, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
nuclear factor 1 B-type, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
palmitoyltransferase ZDHHC21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
palmitoyltransferase ZDHHC21, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
palmitoyltransferase ZDHHC21, transcript variant X3
phospholipase A-2-activating protein-like
HAUS augmin-like complex subunit 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HAUS augmin-like complex subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
HAUS augmin-like complex subunit 6 isoform X2
HAUS augmin-like complex subunit 6 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
tripartite motif-containing protein 16-like
zinc finger protein 3, transcript variant X1
zinc finger protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
stabilizer of axonemal microtubules 2-like, transcript variant X2
stabilizer of axonemal microtubules 2-like isoform X2
stabilizer of axonemal microtubules 2-like, transcript variant X1
stabilizer of axonemal microtubules 2-like, transcript variant X3
stabilizer of axonemal microtubules 2-like isoform X1
stabilizer of axonemal microtubules 2-like isoform X3
zinc finger HIT domain-containing protein 1
uncharacterized si:ch211-119e14.1, transcript variant X2
uncharacterized si:ch211-119e14.1, transcript variant X1
uncharacterized protein si:ch211-119e14.1
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
deltex 4, E3 ubiquitin ligase a, transcript variant X2
deltex 4, E3 ubiquitin ligase a, transcript variant X1
Myb/SANT-like DNA-binding domain containing 1
myb/SANT-like DNA-binding domain-containing protein 1
regulator of G-protein signaling 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G-protein signaling 12, transcript variant X1
regulator of G-protein signaling 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
regulator of G-protein signaling 12 isoform X1
regulator of G-protein signaling 12 isoform X2
hepatocyte growth factor activator, transcript variant X1
hepatocyte growth factor activator, transcript variant X2
hepatocyte growth factor activator isoform X1
hepatocyte growth factor activator isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable tRNA (uracil-O(2)-)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid scramblase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid scramblase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phospholipid scramblase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phospholipid scramblase 2, transcript variant X2
phospholipid scramblase 2, transcript variant X1
CTD nuclear envelope phosphatase 1A, transcript variant X2
CTD nuclear envelope phosphatase 1A, transcript variant X1
CTD nuclear envelope phosphatase 1A isoform X1
CTD nuclear envelope phosphatase 1A isoform X2
gamma-aminobutyric acid receptor-associated protein
G protein pathway suppressor 2, transcript variant X1
G protein pathway suppressor 2, transcript variant X2
G protein pathway suppressor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
G protein pathway suppressor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
G protein pathway suppressor 2 isoform X1
G protein pathway suppressor 2 isoform X2
G protein pathway suppressor 2 isoform X3
G protein pathway suppressor 2 isoform X4
eukaryotic translation initiation factor 5A-1
Y-box-binding protein 2-A, transcript variant X2
Y-box-binding protein 2-A, transcript variant X3
Y-box-binding protein 2-A, transcript variant X1
Y-box-binding protein 2-A, transcript variant X5
Y-box-binding protein 2-A, transcript variant X4
solute carrier family 2, facilitated glucose transporter member 4-like
cellular tumor antigen p53, transcript variant X1
cellular tumor antigen p53, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: DNA-directed RNA polymerase II subunit RPB1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC121554246
sex hormone-binding globulin, transcript variant X2
sex hormone-binding globulin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121554579, transcript variant X1
uncharacterized LOC121554579, transcript variant X2
uncharacterized LOC121554579, transcript variant X5
uncharacterized LOC121554579, transcript variant X7
uncharacterized LOC121554579, transcript variant X6
uncharacterized LOC121554579, transcript variant X8
uncharacterized LOC121554579, transcript variant X3
uncharacterized protein LOC121554579 isoform X1
uncharacterized protein LOC121554579 isoform X2
uncharacterized protein LOC121554579 isoform X5
uncharacterized protein LOC121554579 isoform X3
uncharacterized LOC121554579, transcript variant X4
uncharacterized protein LOC121554579 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
serine/threonine-protein phosphatase PP1-beta catalytic subunit
mitogen-activated protein kinase kinase kinase 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121554517, transcript variant X1
uncharacterized LOC121554517, transcript variant X2
uncharacterized LOC121554517, transcript variant X6
uncharacterized LOC121554517, transcript variant X17
uncharacterized LOC121554517, transcript variant X23
uncharacterized LOC121554517, transcript variant X3
uncharacterized LOC121554517, transcript variant X20
uncharacterized LOC121554517, transcript variant X4
uncharacterized LOC121554517, transcript variant X5
uncharacterized LOC121554517, transcript variant X12
uncharacterized LOC121554517, transcript variant X19
uncharacterized LOC121554517, transcript variant X9
uncharacterized LOC121554517, transcript variant X11
uncharacterized LOC121554517, transcript variant X7
uncharacterized LOC121554517, transcript variant X15
uncharacterized LOC121554517, transcript variant X8
uncharacterized LOC121554517, transcript variant X18
uncharacterized LOC121554517, transcript variant X21
uncharacterized LOC121554517, transcript variant X10
uncharacterized LOC121554517, transcript variant X14
uncharacterized LOC121554517, transcript variant X16
uncharacterized LOC121554517, transcript variant X24
uncharacterized LOC121554517, transcript variant X22
uncharacterized LOC121554517, transcript variant X26
uncharacterized LOC121554517, transcript variant X13
uncharacterized LOC121554517, transcript variant X25
serine/arginine repetitive matrix protein 2
DLC1 Rho GTPase activating protein, transcript variant X1
rho GTPase-activating protein 7 isoform X1
DLC1 Rho GTPase activating protein, transcript variant X2
rho GTPase-activating protein 7 isoform X2
uncharacterized LOC121554560, transcript variant X1
uncharacterized protein LOC121554560 isoform X1
uncharacterized LOC121554560, transcript variant X3
uncharacterized LOC121554560, transcript variant X2
uncharacterized protein LOC121554560 isoform X2
acetylcholine receptor subunit beta-like
acetylcholine receptor subunit beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
acetylcholine receptor subunit beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acetylcholine receptor subunit beta-like isoform X1
acetylcholine receptor subunit beta-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UDP glucuronosyltransferase 5 family, polypeptide G1, transcript variant X1
UDP glucuronosyltransferase 5 family, polypeptide G1, transcript variant X2
UDP glucuronosyltransferase 5 family, polypeptide G1 isoform X1
UDP glucuronosyltransferase 5 family, polypeptide G1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
fragile X mental retardation syndrome-related protein 1, transcript variant X4
fragile X mental retardation syndrome-related protein 1, transcript variant X2
fragile X mental retardation syndrome-related protein 1, transcript variant X3
fragile X mental retardation syndrome-related protein 1, transcript variant X1
fragile X mental retardation syndrome-related protein 1 isoform X4
fragile X mental retardation syndrome-related protein 1 isoform X2
fragile X mental retardation syndrome-related protein 1 isoform X3
fragile X mental retardation syndrome-related protein 1 isoform X1
RNA-binding protein 4B, transcript variant X2
RNA-binding protein 4B, transcript variant X3
RNA-binding protein 4B, transcript variant X1
RNA-binding protein 4B, transcript variant X4
TRAF-interacting protein with FHA domain-containing protein A-like
RNA-binding protein 4B-like, transcript variant X1
RNA-binding protein 4B-like, transcript variant X2
RNA-binding protein 4B-like, transcript variant X3
TRAF-interacting protein with FHA domain-containing protein A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC121554585, transcript variant X1
uncharacterized LOC121554585, transcript variant X2
uncharacterized protein LOC121554585 isoform X1
uncharacterized protein LOC121554585 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
LOW QUALITY PROTEIN: nuclear pore complex protein Nup50
uncharacterized protein KIAA0930 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments